Great Valley Advisor Group’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-16,400
| Closed | -$125K | – | 844 |
|
|
2024
Q3 | $125K | Hold |
16,400
| – | – | ﹤0.01% | 814 |
|
|
2024
Q2 | $101K | Sell |
16,400
-1,000
| -6% | -$6.18K | ﹤0.01% | 762 |
|
|
2024
Q1 | $88.3K | Buy |
17,400
+1,100
| +7% | +$5.58K | ﹤0.01% | 732 |
|
|
2023
Q4 | $97.6K | Hold |
16,300
| – | – | ﹤0.01% | 689 |
|
|
2023
Q3 | $115K | Buy |
16,300
+4,200
| +35% | +$29.7K | ﹤0.01% | 649 |
|
|
2023
Q2 | $85.2K | Buy |
12,100
+1,800
| +17% | +$12.7K | ﹤0.01% | 686 |
|
|
2023
Q1 | $85.9K | Buy |
+10,300
| New | +$85.9K | ﹤0.01% | 679 |
|